These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2172016)

  • 21. Lipoxin formation: evaluation of the role and actions of leukotriene A4.
    Serhan CN; Sheppard KA; Fiore S
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():54-62. PubMed ID: 2169183
    [No Abstract]   [Full Text] [Related]  

  • 22. New series of lipoxins isolated from human eosinophils.
    Steinhilber D; Roth HJ
    FEBS Lett; 1989 Sep; 255(1):143-8. PubMed ID: 2507350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion of 5,6-dihydroxyeicosatetraenoic acids. A novel pathway for lipoxin formation by human platelets.
    Tornhamre S; Gigou A; Edenius C; Lellouche JP; Lindgren JA
    FEBS Lett; 1992 Jun; 304(1):78-82. PubMed ID: 1618303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel 7-cis-11-trans-lipoxin A4 generated by human neutrophils: total synthesis, spasmogenic activities and comparison with other geometric isomers of lipoxins A4 and B4.
    Nicolaou KC; Marron BE; Veale CA; Webber SE; Dahlén SE; Samuelsson B; Serhan CN
    Biochim Biophys Acta; 1989 May; 1003(1):44-53. PubMed ID: 2713393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15(S)-hydroxyeicosatetraenoic acid (15-HETE) is the major arachidonic acid metabolite in human bronchi.
    Kumlin M; Ohlson E; Björck T; Hamberg M; Granström E; Dahlén B; Zetterström O; Dahlén SE
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():441-4. PubMed ID: 1825578
    [No Abstract]   [Full Text] [Related]  

  • 26. On the relationship between leukotriene and lipoxin production by human neutrophils: evidence for differential metabolism of 15-HETE and 5-HETE.
    Serhan CN
    Biochim Biophys Acta; 1989 Aug; 1004(2):158-68. PubMed ID: 2546590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of lipoxins and other lipoxygenase products by macrophages from the rainbow trout, Oncorhynchus mykiss.
    Pettitt TR; Rowley AF; Barrow SE; Mallet AI; Secombes CJ
    J Biol Chem; 1991 May; 266(14):8720-6. PubMed ID: 1902832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoxins stimulate prostacyclin generation by human endothelial cells.
    Brezinski ME; Gimbrone MA; Nicolaou KC; Serhan CN
    FEBS Lett; 1989 Mar; 245(1-2):167-72. PubMed ID: 2494071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ionophore A23187-induced leukotriene biosynthesis in equine granulocytes-neutrophils, but not eosinophils require exogenous arachidonic acid.
    Lindberg A; Tornhamre S; Mugnai S; Lindgren J
    Biochim Biophys Acta; 1998 Mar; 1391(2):247-55. PubMed ID: 9555040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of lipoxins by alveolar macrophages.
    Kim SJ
    Biochem Biophys Res Commun; 1988 Jan; 150(2):870-6. PubMed ID: 3124841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation and proliferative effects of lipoxins in human bone marrow.
    Stenke L; Mansour M; Edenius C; Reizenstein P; Lindgren JA
    Biochem Biophys Res Commun; 1991 Oct; 180(1):255-61. PubMed ID: 1930222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood.
    Brezinski DA; Serhan CN
    Biol Mass Spectrom; 1991 Feb; 20(2):45-52. PubMed ID: 1883860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers.
    Chavis C; Chanez P; Vachier I; Bousquet J; Michel FB; Godard P
    Biochem Biophys Res Commun; 1995 Feb; 207(1):273-9. PubMed ID: 7857276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of lipoxins (LX) and leukotriene B4 (LTB4) production in rat mesangial cells (MC).
    Garrick R; Goodman A; Shen ST; Ogunc S; Wong PY
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():701-6. PubMed ID: 1847572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical and enzymatic syntheses of lipoxin A: stereochemical assignment of natural lipoxin A and its possible biosynthesis.
    Rokach J; Adams J; Fitzsimmons BJ; Girard Y; Leblanc Y; Evans JF
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():309-12. PubMed ID: 3004141
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release.
    Conti P; Reale M; Barbacane RC; Panara MR; Bongrazio M; Theoharides TC
    Immunol Lett; 1992 Apr; 32(2):117-23. PubMed ID: 1612634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level.
    Chabannes B; Moliere P; Merhi-Soussi F; Poubelle PE; Lagarde M
    Br J Haematol; 2003 Apr; 121(2):341-8. PubMed ID: 12694258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotrienes B4, C4, D4 and E4.
    Claesson HE; Haeggström J
    Eur J Biochem; 1988 Apr; 173(1):93-100. PubMed ID: 2833396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of leukotriene formation in human leukocytes by halothane.
    Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S
    Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of formation of leukotrienes and lipoxins from arachidonic acid catalyzed by homogenous lipoxygenase from potato tubers.
    Reddy CC; Whelan J; Rao MK; Reddanna P
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():132-6. PubMed ID: 2526457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.